Technical Analysis for ATOS - Atossa Genetics Inc.

Grade Last Price % Change Price Change
grade C 2.6 -0.38% -0.01
ATOS closed down 0.38 percent on Friday, May 24, 2019, on 4 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Up
See historical ATOS trend table...

Date Alert Name Type % Chg
Narrow Range Bar Range Contraction 0.00%
NR7 Range Contraction 0.00%
Wide Bands Range Expansion 0.00%
Fell Below 20 DMA Bearish -0.38%
Wide Bands Range Expansion -0.38%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -6.47%
Crossed Above 20 DMA Bullish -6.47%
MACD Bullish Signal Line Cross Bullish -6.47%
Wide Bands Range Expansion -6.47%
Up 3 Days in a Row Strength -6.47%

Older signals for ATOS ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Atossa Genetics, Inc. operates as a healthcare company that focuses on the development and marketing of cellular and molecular diagnostic risk assessment products for breast cancer in the United States. Its diagnostic tests include the ForeCYTE Breast Health Test, which provides personalized information about the 10-year and lifetime risk of breast cancer for women between ages 18 and 65; and the ArgusCYTE Breast Health Test that offers information to help inform breast cancer treatment options and to help monitor potential recurrence. The company also intends to offers FullCYTE Breast Health Test, which is in development to assess the individual breast ducts for pre-cancerous changes in women; and NextCYTE Breast Cancer Test that is in the prevalidation phase to profile breast cancer specimens for prediction of treatment outcomes and distant recurrence in women newly diagnosed with breast cancer. Atossa Genetics, Inc. was founded in 2009 and is headquartered in Seattle, Washington.
Medicine Health Cancer Healthcare Breast Cancer Diagnostic Tests Breast Implant Breast Surgery
Is ATOS a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 1 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 7.39
52 Week Low 0.8
Average Volume 2,016,557
200-Day Moving Average 1.9423
50-Day Moving Average 3.1068
20-Day Moving Average 2.7235
10-Day Moving Average 2.564
Average True Range 0.2449
ADX 26.15
+DI 26.1471
-DI 18.9336
Chandelier Exit (Long, 3 ATRs ) 3.5253
Chandelier Exit (Short, 3 ATRs ) 3.0347
Upper Bollinger Band 3.133
Lower Bollinger Band 2.314
Percent B (%b) 0.35
BandWidth 30.071599
MACD Line -0.0965
MACD Signal Line -0.1027
MACD Histogram 0.0062
Fundamentals Value
Market Cap 30.43 Million
Num Shares 11.7 Million
EPS -1.95
Price-to-Earnings (P/E) Ratio -1.33
Price-to-Sales 0.00
Price-to-Book 2.23
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.75
Resistance 3 (R3) 2.74 2.68 2.73
Resistance 2 (R2) 2.68 2.64 2.69 2.72
Resistance 1 (R1) 2.64 2.62 2.61 2.65 2.71
Pivot Point 2.58 2.58 2.57 2.59 2.58
Support 1 (S1) 2.54 2.54 2.51 2.55 2.49
Support 2 (S2) 2.48 2.52 2.49 2.48
Support 3 (S3) 2.44 2.48 2.48
Support 4 (S4) 2.45